2',3'-cyclic-nucleotide phosphodiesterases

Preferred Label : 2',3'-cyclic-nucleotide phosphodiesterases;

MeSH definition : Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.;

MeSH synonym : cnpase; nucleotide phosphodiesterase, 2',3'-cyclic; nucleotide phosphodiesterase, 2,3-cyclic; nucleotide phosphodiesterases, 2',3'-cyclic; nucleotide phosphodiesterases, 2,3-cyclic; phosphodiesterases, 2',3'-cyclic nucleotide; phosphodiesterases, 2,3-cyclic nucleotide; phosphodiesterases, 2',3'-cyclic-nucleotide; 2,3 cyclic nucleotide phosphodiesterases; 2',3'-cyclic nucleotide phosphodiesterase; 2,3-cyclic nucleotide phosphodiesterase; 2,3-cyclic nucleotide phosphodiesterases; 2',3' cyclic nucleotide phosphodiesterase; phosphodiesterase, 2',3'-cyclic nucleotide; 2,3 cyclic nucleotide phosphodiesterase; phosphodiesterase, 2,3-cyclic nucleotide; 2',3'-Cyclic nucleotide phosphodiesterases; 2',3' cyclic nucleotide phosphodiesterases;

Registry Number MeSH : EC 3.1.4.-;

MeSH annotation : DF: 2 3 CYCL NPD;

Is substance : O;

Details

Origin ID

D015087;

UMLS CUI

C0000184;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 7-chloro-5-propyl-1,2,4-triazolo(4,3-a)quinoxaline-1,4(2H,5H)-dione [MeSH Supplementary Concept]
- KS 501 [MeSH Supplementary Concept]
- KS 502 [MeSH Supplementary Concept]
- cephalochromin [MeSH Supplementary Concept]
- griseolic acid 8'-pivaloyloxymethyl ester [MeSH Supplementary Concept]
- neucrassin, neurospora [MeSH Supplementary Concept]
- siguazodan [MeSH Supplementary Concept]
Record concept(s)
- 2',3'-Cyclic-Nucleotide phosphodiesterases [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2',3'-cyclic nucleotide 2'-phosphodiesterase [MeSH Supplementary Concept]
- CpdB protein, E coli [MeSH Supplementary Concept]
- gRICH68 protein, carassius auratus [MeSH Supplementary Concept]
- gRICH70 protein, carassius auratus [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients